Philippine President Marcos Accused Of Drug Use By Sister, Senator Imee
Senator Imee Marcos accused her brother, Philippine President Ferdinand“Bongbong” Marcos Jr., of drug use.
She made the statement on Monday (November 17) during the second day of Iglesia Ni Cristo's“Rally for Transparency and a Better Democracy” at Quirino Grandstand in Manila.
Recommended For YouSpeaking before rally attendees, the senator claimed that her family had long been aware of what she described as the President's“drug problem,” saying the issue dates back to their youth.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
“Even when Bongbong and I were young, our whole family already knew the problem he had,” she said in Tagalog.“I knew he was using drugs. The family knew - this is serious.”
She recalled convincing her brother to marry, believing it would bring stability to his life. The senator alleged that First Lady Liza Araneta-Marcos was involved in drug use as well.
“His addiction worsened because it turns out both husband and wife are using,” she added.
The senator said her main concern was her brother's wellbeing rather than his political career. "I can accept it if you lose your position, but I cannot bear losing you," she said.
She urged him to seek professional help, adding,“Put yourself back in order. Seek treatment. Clear the drugs out of your system.”
Was Duterte right?Senator Imee Marcos' remarks come roughly a year after former President Rodrigo Duterte publicly accused President Marcos Jr. of drug use and questioned his ability to lead.
At the time, President Marcos dismissed Duterte's allegations, suggesting that the former leader's reported long-term use of fentanyl might have influenced his claims.
As of now, the President has not responded to Senator Marcos' statements made during the rally.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment